Q-omics provides the consensus-scored LINC02768 profile across patient tissues and cancer cell-line models. LINC02768 expression is associated with patient survival in 24 of 34 cancer types, with the highest sampling consensus in LGG. Among the 18 cancer types available for tumor–normal comparison, LINC02768 is differentially expressed in 12, with the highest sampling consensus in HNSC. Additionally, LINC02768 RNA expression shows 12,742 significant gene co-expression associations, with the highest sampling consensus in TGCT. Together, these results highlight LGG, HNSC, and TGCT as cancer lineages where LINC02768 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02768 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02768 survival associations across molecular data types. LINC02768 RNA expression shows survival associations in the most cancer types (24). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02768 RNA expression–survival associations across cancer types. High LINC02768 expression shows unfavorable associations in LGG, BLCA, COAD and STAD, but favorable associations in LIHC and SARC. The LGG Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify LGG as the clearest survival context for LINC02768 RNA expression.
This table summarizes LINC02768 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 12. The strongest signals are observed in HNSC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02768. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02768 shows lower tumor expression in UCEC, KICH and BRCA and higher tumor expression in HNSC, KIRC and THCA. The HNSC box plot shows higher LINC02768 RNA expression in tumor versus normal tissue (log2 FC = +1.402, t-test p < 0.001).
This table shows molecular features associated with LINC02768 in patient tissues and cancer cell lines. In patient samples, LINC02768 shows the broadest associations at the RNA and protein expression levels, with TGCT recurring as the lineage with the largest associated feature set.
